CURE GLAUCOMA FOUNDATION (EIN 811231641) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2014

Legal Domicile

Principal Officer

Mike Kettles

Phone

2147659716

Tax Period

2024-01-01 to 2024-12-31

CURE GLAUCOMA FOUNDATION, founded in 2014, is a small nonprofit in the International Affairs sector that reported $268K in total revenue in fiscal year 2024. Revenue fell 45% from the prior year — a significant decline worth monitoring. Expenses of $235K left a modest 12% surplus.

Mission

The mission of Cure Glaucoma is to improve glaucoma by funding transformational research, disseminating knowledge and expanding treatment availability through global outreach efforts.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $255,693

Program Service Revenue $0

Investment Income $12,031

Other Revenue $0

TOTAL REVENUE $267,724

Expense Breakdown

Grants Paid $25,125

Salaries & Benefits $32,295

Fundraising Expenses $43,998

Program Expenses $179,062

Other Expenses $177,281

TOTAL EXPENSES $234,701

Year-over-Year Comparison

	2024	2023	Change
Revenue	$267,724	$484,375	-0.4%
Expenses	$234,701	$543,318	-0.6%
Net Income	$33,023	$-58,943	-1.6%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$25,738

Total Directors

$25,738

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Mike Kettles	Exec Dir/Treas	40.00	Officer Director	$25,738	$0	$25,738
W Stephen Love	President	1.00	Officer Director	$0	$0	$0
Helen L Kornmann MD PhD	Secretary	1.00	Officer Director	$0	$0	$0
Davinder S Grover MD MPH	Director	1.00	Director	$0	$0	$0
Joseph K Haggerty	Director	1.00	Director	$0	$0	$0
Bradley F Jost MD	Director	1.00	Director	$0	$0	$0
Ronald L Fellman MD	Director	1.00	Director	$0	$0	$0
Joan Taylor MD	Director	1.00	Director	$0	$0	$0
Orlando Carvalho	Director	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$267,724	$234,701	$165,083	$33,023
2023	$484,375	$543,318	$132,060	$-58,943
2022	$794,009	$884,180	$184,928	$-90,171
2021	$219,177	$193,778	$275,099	$25,399
2020	$234,455	$117,635	$249,639	$116,820
2019	$1,091,783	$1,177,019	$129,562	$-85,236
2018	$616,271	$553,381	$206,630	$62,890

CURE GLAUCOMA FOUNDATION